Kenneth Erland Johnson - Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs at XERIS PHARMACEUTICALS INC

Issuer-level insider activity

Role
Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs
Issuer ticker
XERS
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Kenneth Erland Johnson since 06 Sep 2025

Reported holdings for Kenneth Erland Johnson in XERIS PHARMACEUTICALS INC

Form 4 holding Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs

XERIS PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
05 Oct 2021
Price
Ownership
Direct
Form 4 holding Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs

XERIS PHARMACEUTICALS INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Oct 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Kenneth Erland Johnson in XERIS PHARMACEUTICALS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .